---
title: "12 Health Care Stocks Moving In Thursday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274969631.md"
description: "In Thursday's pre-market session, several health care stocks saw significant movements. Gainers included CytoMed Therapeutics (+27.1% to $1.08), Anbio Biotechnology (+18.15% to $27.21), and ALX Oncology Holdings (+16.41% to $2.34). Conversely, losers included ENDRA Life Sciences (-11.8% to $3.43), Omnicell (-11.12% to $41.5), and Agape ATP (-9.05% to $0.08). Market values for these companies varied, with Align Technology holding a market cap of $11.6 billion, while others like Nexalin Technology and Can Fite Biopharma had lower valuations."
datetime: "2026-02-05T12:05:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274969631.md)
  - [en](https://longbridge.com/en/news/274969631.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274969631.md)
---

# 12 Health Care Stocks Moving In Thursday's Pre-Market Session

### Gainers

-   **CytoMed Therapeutics** (NASDAQ:GDTC) shares increased by 27.1% to $1.08 during Thursday's pre-market session. The market value of their outstanding shares is at $9.9 million.
-   **Anbio Biotechnology** (NASDAQ:NNNN) stock increased by 18.15% to $27.21. The market value of their outstanding shares is at $1.0 billion.
-   **ALX Oncology Holdings** (NASDAQ:ALXO) shares moved upwards by 16.41% to $2.34. The company's market cap stands at $263.7 million.
-   **Nexalin Technology** (NASDAQ:NXL) stock moved upwards by 16.19% to $0.66. The market value of their outstanding shares is at $10.5 million.
-   **Can Fite Biopharma** (AMEX:CANF) shares moved upwards by 15.34% to $4.66. The company's market cap stands at $5.2 million.
-   **Align Technology** (NASDAQ:ALGN) shares moved upwards by 10.43% to $178.13. The company's market cap stands at $11.6 billion. As per the press release, Q4 earnings came out yesterday.

### Losers

-   **ENDRA Life Sciences** (NASDAQ:NDRA) shares decreased by 11.8% to $3.43 during Thursday's pre-market session. The market value of their outstanding shares is at $4.5 million.
-   **Omnicell** (NASDAQ:OMCL) shares decreased by 11.12% to $41.5. The company's market cap stands at $2.1 billion. As per the press release, Q4 earnings came out today.
-   **Agape ATP** (NASDAQ:ATPC) shares declined by 9.05% to $0.08. The market value of their outstanding shares is at $4.2 million.
-   **TuHURA Biosciences** (NASDAQ:HURA) shares fell 8.93% to $0.42. The market value of their outstanding shares is at $26.1 million.
-   **Accuray** (NASDAQ:ARAY) shares fell 7.82% to $0.7. The market value of their outstanding shares is at $85.7 million. As per the press release, Q2 earnings came out yesterday.
-   **Tempest Therapeutics** (NASDAQ:TPST) shares decreased by 7.57% to $2.2. The company's market cap stands at $11.7 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [ATPC.US](https://longbridge.com/en/quote/ATPC.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [OMCL.US](https://longbridge.com/en/quote/OMCL.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [ALGN.US](https://longbridge.com/en/quote/ALGN.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [NNNN.US](https://longbridge.com/en/quote/NNNN.US.md)
- [ALXO.US](https://longbridge.com/en/quote/ALXO.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [GDTC.US](https://longbridge.com/en/quote/GDTC.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)

## Related News & Research

- [CytoMed Chairman Moves to Boost Personal Stake Through Private Share Purchases](https://longbridge.com/en/news/286569308.md)
- [Sequoia Financial Advisors LLC Has $1.25 Million Stock Position in Align Technology, Inc. $ALGN](https://longbridge.com/en/news/286230284.md)
- [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md)
- [Analyst Reaffirms Buy on PAVmed, Citing Oncology Platform Momentum and Partnerships; Price Target Maintained at $16](https://longbridge.com/en/news/286945953.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)